Hirosumi J[au] - Search Results

Year	Number of Results
1983	1
1984	1
1987	3
1988	2
1989	1
1992	1
1995	3
1997	3
2000	1
2002	2
2003	3
2004	1
2005	2
2006	1
2007	1
2017	1
2022	0

1

The Sodium Glucose Cotransporter 2 Inhibitor Ipragliflozin Promotes Preferential Loss of Fat Mass in Non-obese Diabetic Goto-Kakizaki Rats.

Takasu T, Hayashizaki Y, Hirosumi J, Minoura H, Amino N, Kurosaki E, Takakura S. Takasu T, et al. Among authors: hirosumi j. Biol Pharm Bull. 2017;40(5):675-680. doi: 10.1248/bpb.b16-00964. Biol Pharm Bull. 2017. PMID: 28458353 Free article.

2

Inflammatory responses in cuff-induced atherosclerosis in rabbits.

Hirosumi J, Nomoto A, Ohkubo Y, Sekiguchi C, Mutoh S, Yamaguchi I, Aoki H. Hirosumi J, et al. Atherosclerosis. 1987 Apr;64(2-3):243-54. doi: 10.1016/0021-9150(87)90252-8. Atherosclerosis. 1987. PMID: 3606722

3

Functional in vivo interactions between JNK1 and JNK2 isoforms in obesity and insulin resistance.

Tuncman G, Hirosumi J, Solinas G, Chang L, Karin M, Hotamisligil GS. Tuncman G, et al. Among authors: hirosumi j. Proc Natl Acad Sci U S A. 2006 Jul 11;103(28):10741-6. doi: 10.1073/pnas.0603509103. Epub 2006 Jul 3. Proc Natl Acad Sci U S A. 2006. PMID: 16818881 Free PMC article.

4

Pharmacological characteristics of a novel nonthiazolidinedione insulin sensitizer, FK614.

Minoura H, Takeshita S, Ita M, Hirosumi J, Mabuchi M, Kawamura I, Nakajima S, Nakayama O, Kayakiri H, Oku T, Ohkubo-Suzuki A, Fukagawa M, Kojo H, Hanioka K, Yamasaki N, Imoto T, Kobayashi Y, Mutoh S. Minoura H, et al. Among authors: hirosumi j. Eur J Pharmacol. 2004 Jun 28;494(2-3):273-81. doi: 10.1016/j.ejphar.2004.04.038. Eur J Pharmacol. 2004. PMID: 15212984

5

A central role for JNK in obesity and insulin resistance.

Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M, Hotamisligil GS. Hirosumi J, et al. Nature. 2002 Nov 21;420(6913):333-6. doi: 10.1038/nature01137. Nature. 2002. PMID: 12447443

6

Choleretic actions of insulin-like growth factor-I, prednisolone, and ursodeoxycholic acid in rats.

Mabuchi M, Kawamura I, Fushimi M, Takeshita S, Takakura S, Hirosumi J, Mutoh S. Mabuchi M, et al. Among authors: hirosumi j. Dig Dis Sci. 2003 Jul;48(7):1398-405. doi: 10.1023/a:1024140116705. Dig Dis Sci. 2003. PMID: 12870804

7

A protein which facilitates assembly of nucleosome-like structures in vitro in mammalian cells.

Ishimi Y, Yasuda H, Hirosumi J, Hanaoka F, Yamada M. Ishimi Y, et al. Among authors: hirosumi j. J Biochem. 1983 Sep;94(3):735-44. doi: 10.1093/oxfordjournals.jbchem.a134414. J Biochem. 1983. PMID: 6643419 Free article.

8

Insulin-like growth factor-I enhances choleretic action of FK506 in rats.

Mabuchi M, Kawamura I, Takeshita S, Fushimi M, Takakura S, Hirosumi J, Mutoh S. Mabuchi M, et al. Among authors: hirosumi j. Transplant Proc. 2003 Jun;35(4):1596-8. doi: 10.1016/s0041-1345(03)00358-0. Transplant Proc. 2003. PMID: 12826230

9

Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.

Minoura H, Takeshita S, Kimura C, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Mutoh S. Minoura H, et al. Among authors: hirosumi j. Diabetes Obes Metab. 2007 May;9(3):369-78. doi: 10.1111/j.1463-1326.2006.00619.x. Diabetes Obes Metab. 2007. PMID: 17391165

10

Ameliorating effect of FK614, a novel nonthiazolidinedione peroxisome proliferator-activated receptor gamma agonist, on insulin resistance in Zucker fatty rat.

Minoura H, Takeshita S, Yamamoto T, Mabuchi M, Hirosumi J, Takakura S, Kawamura I, Seki J, Manda T, Ita M, Mutoh S. Minoura H, et al. Among authors: hirosumi j. Eur J Pharmacol. 2005 Sep 5;519(1-2):182-90. doi: 10.1016/j.ejphar.2005.05.042. Eur J Pharmacol. 2005. PMID: 16039648

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results